Example: Heart Attack

Search clinical trials for: Aluminum phosphate

Total 57 results

NCT02200237

Completed

A Clinical Study for Inactivated Vaccine Against EV71

Conditions: Enterovirus 71 Human
NCT03165344

Completed

Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma

Conditions: Esophageal Stenosis Acquired
NCT03026348

Completed

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Conditions: Respiratory Syncytial Viruses
NCT03060629

Active, not recruiting

A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa

Conditions: HIV-1
NCT01711645

Completed

Tdap Vaccine in Post-Partum Women

Conditions: Diphtheria; Pertussis; Tetanus
NCT00347555

Completed

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly

Conditions: Plasmodium Falciparum Malaria
NCT01026246

Completed

EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Conditions: Plasmodium Falciparum Malaria
NCT01986010

Completed

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

Conditions: Cytomegalovirus Infections
NCT04658667

Not yet recruiting

HIV Vaccine in HIV-uninfected Adults

Conditions: HIV
NCT01404182

Completed

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Conditions: Influenza
NCT01010893

Completed

Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

Conditions: Influenza
NCT01100294

Completed

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

Conditions: Influenza
NCT01459276

Completed

A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Conditions: Influenza
NCT01407978

Completed

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Conditions: Novel 2009 Influenza H1N1; Influenza, Human
NCT04258995

Completed

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS

Conditions: Group B Streptococcal Infections
NCT01977196

Completed

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

Conditions: Healthy
NCT02740777

Unknown status

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Conditions: Human Papillomavirus; Cervical Intraepithelial Neoplasia; Persistent Infection
NCT01119157

Unknown status

Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines

Conditions: Healthy Volunteers
NCT03307915

Active, not recruiting

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Conditions: Human Immunodeficiency Virus
NCT02788045

Active, not recruiting

Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

Conditions: Healthy
NCT02685020

Completed

Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

Conditions: Healthy
NCT01986322

Completed

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

Conditions: Healthy
NCT02123433

Completed

Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults

Conditions: HIV Infection; Pneumococcal Infections
NCT01451801

Unknown status

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Conditions: Hepatitis B
NCT01986335

Completed

Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial

Conditions: Healthy